ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) announced its participation in the 21st Annual Oppenheimer Healthcare Conference on March 16, 2021. The company's management will conduct a virtual fireside chat at 3:50 PM ET and hold individual meetings with investors. A live webcast will be available on ViewRay's investor website, with a replay accessible for seven days following the event. ViewRay is known for its MRIdian® radiation therapy system, which is designed to tackle unique challenges in advanced radiation oncology.

News Market Reaction – VRAY

+5.34%

+5.34% Session move

In the trading session that priced this news, VRAY gained 5.34%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, March 5, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in the 21^st Annual Oppenheimer Healthcare Conference on Tuesday, March 16, 2021.  ViewRay will be conducting a virtual fireside chat at 3:50 PM ET, as well as hosting 1x1 meetings with investors.

A live webcast of the Company's fireside chat will be available on the "Financial Events and Webinars" section of ViewRay's investor website at:  https://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the presentation will be available for the following 7 days.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:http://www.prnewswire.com/news-releases/viewray-to-participate-in-the-21st-annual-oppenheimer-healthcare-conference-301241544.html

SOURCE ViewRay, Inc.

FAQ

When will ViewRay participate in the Oppenheimer Healthcare Conference?

ViewRay will participate in the 21st Annual Oppenheimer Healthcare Conference on March 16, 2021.

What time is ViewRay's fireside chat at the Oppenheimer Conference?

ViewRay's fireside chat is scheduled for 3:50 PM ET on March 16, 2021.

How can I watch ViewRay's fireside chat?

You can watch ViewRay's fireside chat via a live webcast on their investor website in the 'Financial Events and Webinars' section.

Will there be a replay of ViewRay's presentation?

Yes, a replay of ViewRay's presentation will be available for seven days after the event.

What is the focus of ViewRay's product, MRIdian?

MRIdian is a radiation therapy system specifically designed to address challenges in advanced radiation oncology, including beam distortion and skin toxicity.